LONG-TERM OUTCOMES WITH EMICIZUMAB PROPHYLAXIS FOR SEVERE HAEMOPHILIA A WITHOUT FVIII INHIBITORS: EFFICACY AND SAFETY ANALYSES FROM HAVEN 3 & 4

被引：0
|
作者：
Mahlangu, J. [1 ,2 ]
Jimenez-Yuste, V. [3 ]
Ventriglia, G. [4 ]
Niggli, M. [4 ]
Barlera, S. [5 ]
Hermans, C. [6 ]
Lehle, M. [4 ]
Chowdary, P. [7 ]
Jew, L. [8 ]
Windyga, J. [9 ]
Frenzel, L. [10 ]
Castaman, G. [11 ]
Pipe, S. W. [12 ]
机构：
[1] Univ Witwatersrand, Johannesburg, South Africa
[2] NHLS, Johannesburg, South Africa
[3] Univ Autonoma Madrid, La Paz Univ Hosp, Madrid, Spain
[4] F Hoffmann La Roche Ltd, Basel, Switzerland
[5] Parexel Int, Milan, Italy
[6] Catholic Univ Louvain UCLouvain, Univ Clin St Luke, Brussels, Belgium
[7] Royal Free London, Katharine Dormandy Haemophilia & Thrombosis Unit, London, England
[8] Genentech Inc, San Francisco, CA USA
[9] Inst Hematol & Transfus Med, Dept Hemostasis Disorders & Internal Med, Lab Hemostasis andMetabol Dis, Warsaw, Poland
[10] Necker Enfants Malades Hosp, Dept Hematol, Paris, France
[11] Careggi Univ Hosp, Florence, Italy
[12] Univ Michigan, Dept Pediat & Pathol, Ann Arbor, MI USA
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO135
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [41] Long-term immunogenicity, safety and efficacy of human-cl rhFVIII in previously treated children with severe haemophilia A
    Klukowska, Anna
    Vdovin, Vladimir
    Szczepanski, Tomasz
    Irena, Dzhunova
    Liesner, Raina
    Bichler, Johann
    HAEMOPHILIA, 2016, 22 : 52 - 52
  • [42] Long-term safety and efficacy of rVIII-SingleChain in patients with severe haemophilia A: Interim results from a phase 3B extension study
    Mahlangu, J.
    Karim, F. Abdul
    Stasyshyn, O.
    Korczowski, B.
    Brainsky, A.
    Lucas, S.
    Li, Y.
    Pabinger, I.
    HAEMOPHILIA, 2019, 25 : 148 - 149
  • [43] Long-term safety and efficacy results from the phase 3b, open-label, multicentre Continuation study of rurioctocog alfa pegol for prophylaxis in previously treated patients with severe haemophilia A
    Chowdary, Pratima
    Mullins, Eric S.
    Konkle, Barbara A.
    McGuinn, Catherine
    Park, Young Shil
    Stasyshyn, Oleksandra
    Zulfikar, Bulent
    Engl, Werner
    Tangada, Srilatha
    HAEMOPHILIA, 2020, 26 (04) : E168 - E178
  • [44] Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan
    Yoshioka, A
    Shima, M
    Fukutake, K
    Takamatsu, J
    Shirahata, A
    HAEMOPHILIA, 2001, 7 (03) : 242 - 249
  • [45] Long-term intracranial safety and efficacy analyses from the phase III CROWN study
    Bearz, A.
    Felip, E.
    Mazieres, J.
    de Marinis, F.
    Bauer, T.
    Polli, A.
    Messina, R.
    Thurm, H.
    Thomaidou, D.
    Mok, T. S. K.
    Solomon, B. J.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S998 - S999
  • [46] AOZORA: long-term safety and joint health in paediatric persons with haemophilia A without factor VIII inhibitors receiving emicizumab - protocol for a multicentre, open-label, phase IV clinical study
    Shima, Midori
    Takedani, Hideyuki
    Kitsukawa, Kaoru
    Taki, Masashi
    Ishiguro, Akira
    Nagao, Azusa
    Yamaguchi-Suita, Haruko
    Kyogoku, Yui
    Yoshida, Seitaro
    Nogami, Keiji
    BMJ OPEN, 2022, 12 (06): : e059667
  • [47] Long-term patterns of safety and efficacy of bleeding prophylaxis with turoctocog alfa (NovoEight®) in previously treated patients with severe haemophilia A: interim results of the guardian™2 extension trial
    Ozelo, M.
    Misgav, M.
    Karim, F. Abdul
    Lentz, S. R.
    Martin-Salces, M.
    Matytsina, I.
    Saugstrup, T.
    Santagostino, E.
    HAEMOPHILIA, 2015, 21 (05) : E436 - E439
  • [48] BAY 81-8973 Demonstrates Long-Term Safety and Efficacy in Children With Severe Haemophilia A: Results From the LEOPOLD Kids Extension Study
    Ljung, Rolf
    Chan, Anthony K. C.
    Ahuja, Sanjay P.
    Mancuso, Maria Elisa
    Marquez, Jose Francisco Cabre
    Volk, Florian
    Blanchette, Victor
    Kerlin, Bryce A.
    Trakymiene, Sonata Saulyte
    Glosli, Heidi
    Kenet, Gili
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (03) : 556 - 565
  • [49] SUBCUTANEOUS CONCIZUMAB PROPHYLAXIS IN PATIENTS WITH HAEMOPHILIA A OR B WITH INHIBITORS: EFFICACY AND SAFETY RESULTS BY HAEMOPHILIA SUBTYPE FROM THE PHASE 3 EXPLORER7 TRIAL
    Mathias, M.
    Cepo, K.
    d'Oiron, R.
    Frei-Jones, M.
    Goh, A. -S.
    Odgaard-Jensen, J.
    HAEMOPHILIA, 2023, 29 : 17 - 17
  • [50] Safety and Efficacy of Living Donor Hepatectomy Without Systemic Heparinization: Short-and Long-Term Outcomes
    Kim, Joo Dong
    Kwak, Sang-Gyu
    Choi, Dong Lak
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (06) : 1778 - 1783
12345